{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:25:50Z","timestamp":1773685550630,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liverpool School of Tropical Medicine."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijpddr.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T08:19:23Z","timestamp":1410855563000},"page":"278-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis"],"prefix":"10.1016","volume":"4","author":[{"given":"Kelly L.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Umareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Townson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Specht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Pfarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Altmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2014.09.001_b0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijpara.2007.12.006","article-title":"Infection of the intermediate mite host with Wolbachia-depleted Litomosoides sigmodontis microfilariae: impaired L1 to L3 development and subsequent sex-ratio distortion in adult worms","volume":"38","author":"Arumugam","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.8.6.713","article-title":"Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs","volume":"8","author":"Barza","year":"1975","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QCO.0b013e32833fdee5","article-title":"Elimination of lymphatic filariasis: do we have the drugs to complete the job?","volume":"23","author":"Bockarie","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0025","doi-asserted-by":"crossref","first-page":"e2083","DOI":"10.1371\/journal.pone.0002083","article-title":"The endosymbiont Wolbachia pipientis induces the expression of host antioxidant proteins in an Aedes albopictus cell line","volume":"3","author":"Brennan","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0030","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1371\/journal.pntd.0000708","article-title":"The economic benefits resulting from the first 8 years of the global programme to eliminate lymphatic filariasis (2000\u20132007)","volume":"4","author":"Chu","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0035","unstructured":"Clare, R., Cook, D.A., Johnston, K.L., Ford, L., Ward, S.A., Taylor, M.J., in press. Development and validation of a high throughput anti-Wolbachia whole cell screen: a route to macrofilaricidal drugs against onchocerciasis and lympatic filariasis. J. Biomol. Screen."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0040","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1371\/journal.pntd.0002032","article-title":"African programme for onchocerciasis control 1995\u20132015: model-estimated health impact and cost","volume":"7","author":"Coffeng","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0045","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0050","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.47.5.1665-1671.2003","article-title":"Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR","volume":"47","author":"Fenollar","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/ph4050681","article-title":"Expanding the antimalarial drug arsenal-now, but how?","volume":"4","author":"Grimberg","year":"2011","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/47.5.659","article-title":"In vitro activity of antimicrobial agents against the endosymbiont Wolbachia pipientis","volume":"47","author":"Hermans","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/QCO.0b013e328315cde7","article-title":"Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis","volume":"21","author":"Hoerauf","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI4768","article-title":"Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility","volume":"103","author":"Hoerauf","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-3156.2000.00544.x","article-title":"Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin","volume":"5","author":"Hoerauf","year":"2000","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11908-007-0023-2","article-title":"Wolbachia in filarial parasites: targets for filarial infection and disease control","volume":"9","author":"Johnston","year":"2007","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1756-3305-3-99","article-title":"Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes","volume":"3","author":"Johnston","year":"2010","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1087057113511270","article-title":"Overcoming the challenges of drug discovery for neglected tropical diseases: the A-WOL experience","volume":"19","author":"Johnston","year":"2014","journal-title":"J. Biomol. Screen."},{"issue":"Suppl 1","key":"10.1016\/j.ijpddr.2014.09.001_b0100","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2180-12-S1-S7","article-title":"Influence of Wolbachia on host gene expression in an obligatory symbiosis","volume":"12","author":"Kremer","year":"2012","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0105","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJM199605023341808","article-title":"Antiparasitic drugs","volume":"334","author":"Liu","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pt.2011.10.003","article-title":"Elimination of onchocerciasis from Africa: possible?","volume":"28","author":"Mackenzie","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0115","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.50.3.922-927.2006","article-title":"Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal","volume":"50","author":"Makepeace","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2883-2-9","article-title":"Evidence against Wolbachia symbiosis in Loa loa","volume":"2","author":"McGarry","year":"2003","journal-title":"Filaria J."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0125","unstructured":"Mucke, H.A.M., 2010. Drug repositioning: extracting value from prior R&D investments. Insight Pharma Rep. <www.insightpharmareports.com>."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0130","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.1371\/journal.pntd.0001549","article-title":"A research agenda for helminth diseases of humans: intervention for control and elimination","volume":"6","author":"Prichard","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-4894(02)00019-X","article-title":"Brugia malayi: effects of antibacterial agents on larval viability and development in vitro","volume":"101","author":"Rao","year":"2002","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1472-8206.2003.00170.x","article-title":"Ivermectin and filariasis","volume":"17","author":"Richard-Lenoble","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/infdis\/jis341","article-title":"Corallopyronin a specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo","volume":"206","author":"Schiefer","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14787210.7.1.37","article-title":"Prospects for the control of neglected tropical diseases by mass drug administration","volume":"7","author":"Smits","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ijpara.2010.03.004","article-title":"Mitochondrial genes for heme-dependent respiratory chain complexes are up-regulated after depletion of Wolbachia from filarial nematodes","volume":"40","author":"Str\u00fcbing","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-3305-5-53","article-title":"Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis","volume":"5","author":"Tamarozzi","year":"2012","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0165","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0031182013001108","article-title":"Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis","volume":"141","author":"Taylor","year":"2014","journal-title":"Parasitol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1358\/dnp.2009.22.2.1343228","article-title":"The value of drug repositioning in the current pharmaceutical market","volume":"22","author":"Tobinick","year":"2009","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/00034983.2000.11813605","article-title":"Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi","volume":"94","author":"Townson","year":"2000","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2883-5-4","article-title":"Onchocerca parasites and Wolbachia endosymbionts: evaluation of a spectrum of antibiotic types for activity against Onchocerca gutturosa in vitro","volume":"5","author":"Townson","year":"2006","journal-title":"Filaria J."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0190","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1517\/17460441.2.S1.S63","article-title":"Challenges in drug discovery for novel antifilarials","volume":"2","author":"Townson","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0195","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.177.2.1240","article-title":"Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88\/TLR2-dependent manner","volume":"177","author":"Turner","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0200","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1371\/journal.pntd.0000660","article-title":"Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial","volume":"4","author":"Turner","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-3156.2003.01040.x","article-title":"Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability","volume":"8","author":"Volkmann","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0210","doi-asserted-by":"crossref","first-page":"E1638","DOI":"10.1073\/pnas.1203519109","article-title":"Autophagy regulates Wolbachia populations across diverse symbiotic associations","volume":"109","author":"Voronin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-3305-2-39","article-title":"Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon","volume":"2","author":"Wanji","year":"2009","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2014.09.001_b0220","unstructured":"WHO, 2007. Global plan to combat neglected tropical diseases 2008\u20132015. <http:\/\/whqlibdoc.who.int\/hq\/2007\/WHO_CDS_NTD_2007.2003_eng.pdf>."},{"key":"10.1016\/j.ijpddr.2014.09.001_b0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320714000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320714000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:45:25Z","timestamp":1761921925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320714000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2211320714000244"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2014.09.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}